↑↓ navigate open esc close
Czech Republic NEN contract award · ocds-ted-746868-2024-2

Czechia – Antivirals for systemic use – Antivirotika pro systémové použití – CMV – Letermovir, Maribavir

Institut klinické a experimentální medicíny awarded Kč12.7M to Merck Sharp & Dohme s.r.o. for Professional Services & Consulting in December 2024 — one of 690 awards this buyer has made, above its typical award size.

06 Dec 2024
Award date
Kč12.7M
Contract value
690 Awards
Kč9.9M Avg award
Above vs typical

Winning supplier

Merck Sharp & Dohme s.r.o.
49 Awards
17 Buyers
Kč3.1B Total won

Contract description

Czechia – Antivirals for systemic use – Antivirotika pro systémové použití – CMV – Letermovir, Maribavir

Premium

Related awards · Institut klinické a experimentální medicíny

690 awards

The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.

Full dataset

Unlock the full data.

Subscribe to reveal every row, year-over-year trends, and CSV / API export.

Unlock full dataset →

646 more awards from this buyer · full history & CSV export

Premium

Other wins · Merck Sharp & Dohme s.r.o.

49 wins

The supplier's complete win history across every buyer it sells to — not just the handful shown here.

Locked rows — unlock the full dataset below.

Premium · full dataset

See the full award context.

Competing bids, award margins and every related contract for Institut klinické a experimentální medicíny and Merck Sharp & Dohme s.r.o. — one subscription unlocks everything.

Sign Up Free →

Free account · cancel anytime · 14-day money-back

Sign Up